A creatine analog
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

3-Guanidinopropionic Acid

Item No. 16725

Technical Information
Formal Name
N-(aminoiminomethyl)-β-alanine
CAS Number
353-09-3
Synonyms
  • β-GPA
  • PNU 10483
Molecular Formula
C4H9N3O2
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
PBS (pH 7.2): >50 mg/ml
SMILES
NC(NCCC(O)=O)=N
InChi Code
InChI=1S/C4H9N3O2/c5-4(6)7-2-1-3(8)9/h1-2H2,(H,8,9)(H4,5,6,7)
InChi Key
KMXXSJLYVJEBHI-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    3-Guanidinopropionic acid is a creatine analog that alters skeletal muscle energy expenditure. It reduces cellular ATP, creatine, and phosphocreatine levels and stimulates AMP-activated protein kinase (AMPK), activating PPARγ coactivator 1α (PGC-1α).1,2,3,4 PGC-1α activation results in enhanced expression of AMPK, as well as genes for oxidative phosphorylation, electron transport chain, and mitochondrial biogenesis, increasing oxidative muscle fibers, numbers of mitochondria, and motor performance.1,5 3-Guanidinopropionic acid evokes a shift from glycolytic to oxidative metabolism, increased cellular glucose uptake, and increased fatigue tolerance.2 In aged rats, reduced mitochondrial biogenesis in response to chronic activation of AMPK with 3-guanidinopropionic acid leads to metabolic insufficiency that can contribute to muscle loss.6,5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chaturvedi, R.K., Adhihetty, P., Shukla, S., et alImpaired PGC-1α function in muscle in Huntington’s disease. Hum. Mol. Genet. 18(16), 3048-3065 (2009).

    2. Oudman, I., Clark, J.F., and Brewster, L.M. The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: A systematic review. PLoS One 8(1), 1-13 (2013).

    3. Shoubridge, E.A., Challiss, R.A.J., Hayes, D.J., et alBiochemical adaptation in the skeletal muscle of rats depleted of creatine with the substrate analogue β-guanidinopropionic acid. Biochem. J. 232(1), 125-131 (1985).

    4. Boehm, E., Chan, S., Monfared, M., et alCreatine transporter activity and content in the rat heart supplemented by and depleted of creatine. Am. J. Physiol. Endocrinol. Metab. 284(2), E399-E406 (2003).

    5. Reznick, R.M., Zong, H., Li, J., et alAging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 5(2), 151-156 (2007).

    6. Herbst, A., Johnson, C.J., Hynes, K., et alMitochondrial biogenesis drives a vicious cycle of metabolic insufficiency and mitochondrial DNA deletion mutation accumulation in aged rat skeletal muscle fibers. PLoS One 8(3), 1-8 (2013).